Research Highlight | Published:

HEAD AND NECK CANCER

Towards risk-stratified induction regimens

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

    Original article

    1. Haddad, R. I. et al. Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma. Ann. Oncol. https://doi.org/10.1093/annonc/mdy549 (2018)

    Download references

    Author information

    Correspondence to David Killock.

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark